Antiproliferative potential, quantitative structure-activity relationship, cheminformatic and molecular docking analysis of quinoline and benzofuran derivatives
Open Access
- 30 September 2020
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 11 (3), 223-234
- https://doi.org/10.5155/eurjchem.11.3.223-234.2004
Abstract
Quinoline and benzofuran moieties are commonly used for the synthesis of therapeutically beneficial molecules and drugs since they possess a wide range of pharmacological activities including potent anticancer activity as compared to other heterocyclic compounds. Many of well-known antimalarial, antimicrobial, anti-helminthic, analgesic, anti-inflammatory, antiprotozoal, and antitumor compounds contain quinoline/benzofuran skeleton. The aim of this study was to analyze ten new quinoline and eighteen benzofuran derivatives for carcinoma cell line growth inhibition and to predict possible interactions with the target. The anticancer activity of these compounds against colon cancer (HCT-116) and triple-negative breast cancer (MDA-MB-468) cell lines was determined and performed molecular docking to predict the possible interactions. Among ten quinoline derivatives, Q1, Q4, Q6, Q9, and Q10 were found to be the most potent against HCT-116 and MDA-MB-468 with IC50 values ranging from 6.2-99.6 and 2.7-23.6 μM, respectively. Using the IC50 values, a model equation with quantitative structure activity relationship (QSAR) was generated with their descriptors such as HBA1, HBA2, kappa (1, 2 and 3), Balaban index, Wiener index, number of rotatable bonds, log S, log P and total polar surface area (TPSA). The effect of benzofuran derivatives was moderate in cytotoxicity tests and hence only quinolines were considered for further analysis. The molecular docking indicated the mammalian / mechanistic target of rapamycin (mTOR), Topoisomerase I and II as possible targets for these molecules. The predicted results obtained from QSAR and molecular docking analysis of quinoline derivatives showed high correlation in comparison to the results of the cytotoxic assay. Overall, this study indicated that quinolines are more potent as anticancer agents compared to benzofurans. Further, compound Q9 has emerged as a lead molecule which could be the base for further development of more potent anticancer agents.Keywords
This publication has 32 references indexed in Scilit:
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity PathwaysPLOS ONE, 2011
- Chemoinformatics: a historyWIREs Computational Molecular Science, 2011
- A History of Cancer ChemotherapyCancer Research, 2008
- Toward an Improved Clustering of Large Data Sets Using Maximum Common Substructures and Topological FingerprintsJournal of Chemical Information and Modeling, 2008
- Visualizing density maps with UCSF ChimeraJournal of Structural Biology, 2007
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- IV-IVC considerations in the development of immediate-release oral dosage formJournal of Pharmaceutical Sciences, 2005
- Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent ComplexJournal of Medicinal Chemistry, 2005
- The Protein Data BankJBIC Journal of Biological Inorganic Chemistry, 1977